0.206
price down icon9.69%   -0.0221
after-market Dopo l'orario di chiusura: .20 -0.006 -2.91%
loading

Cosmos Health Inc Borsa (COSM) Ultime notizie

pulisher
03:40 AM

Cosmos Health Inc. Announces Proposed Acquisition of Doc Pharma S.A. to Enhance Vertical Integration and Product Portfolio - Quiver Quantitative

03:40 AM
pulisher
03:31 AM

Cosmos Health pursues Doc Pharma deal, adding $6.7M in sales - Stock Titan

03:31 AM
pulisher
10:49 AM

Cosmos Health Secures Additional 180-Day Nasdaq Extension To Regain Bid Price Compliance - TradingView

10:49 AM
pulisher
09:55 AM

Cosmos Health gets Nasdaq extension to regain $1 minimum bid price - Investing.com

09:55 AM
pulisher
09:35 AM

Cosmos Health gets Dec. 7 deadline from Nasdaq; reverse split only last resort - Stock Titan

09:35 AM
pulisher
Jun 10, 2026

Cosmos Health CEO addresses shareholders amid stock decline - Investing.com UK

Jun 10, 2026
pulisher
Jun 10, 2026

Cosmos Health targets $200M revenue by 2029, driven by U.S. expansion - scanx.trade

Jun 10, 2026
pulisher
Jun 10, 2026

$20 Million in Liquid Assets Support Rapid Growth Including Acquisitions, Bio Pharma Production and Nanotechnology Initiatives for Diversified Global Heath Leader Cosmos Health, Inc. (Nasdaq: COSM) - Barchart.com

Jun 10, 2026
pulisher
Jun 10, 2026

Cosmos Health (COSM) Secures Manufacturing Deal with Verisfield S.A. - GuruFocus

Jun 10, 2026
pulisher
Jun 10, 2026

Cosmos Health subsidiary secures manufacturing deal By Investing.com - Investing.com Australia

Jun 10, 2026
pulisher
Jun 10, 2026

Cosmos Health subsidiary secures manufacturing deal - Investing.com

Jun 10, 2026
pulisher
Jun 10, 2026

Cosmos Health Inc. - Via Ritzau

Jun 10, 2026
pulisher
Jun 10, 2026

Cosmos Health CEO addresses shareholders amid stock decline By Investing.com - Investing.com Nigeria

Jun 10, 2026
pulisher
Jun 10, 2026

Cosmos Health CEO Issues Letter to Shareholders: Building - GlobeNewswire

Jun 10, 2026
pulisher
Jun 10, 2026

Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway | FinancialContent - FinancialContent

Jun 10, 2026
pulisher
Jun 10, 2026

Cosmos Health subsidiary secures 5-year manufacturing deal - Investing.com UK

Jun 10, 2026
pulisher
Jun 09, 2026

Cosmos Health (COSM) Launches New Capsule Production and Signs C - GuruFocus

Jun 09, 2026
pulisher
Jun 09, 2026

Cosmos Health subsidiary secures 5-year manufacturing deal By Investing.com - Investing.com South Africa

Jun 09, 2026
pulisher
Jun 09, 2026

Cosmos Health Inc. Subsidiary Cana Laboratories Inaugurates New Capsule Production Line and Secures Contract with Provident Pharmaceuticals - Quiver Quantitative

Jun 09, 2026
pulisher
Jun 09, 2026

Factory upgrade backs 385,000-dose antidepressant deal contract - Stock Titan

Jun 09, 2026
pulisher
Jun 08, 2026

Cosmos Health (COSM) Expands Innovation with Patent Acquisition - GuruFocus

Jun 08, 2026
pulisher
Jun 08, 2026

Cosmos Health subsidiary acquires nanotechnology patent By Investing.com - Investing.com Australia

Jun 08, 2026
pulisher
Jun 08, 2026

Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives - The Manila Times

Jun 08, 2026
pulisher
Jun 08, 2026

Cosmos Health subsidiary acquires nanotechnology patent - Investing.com

Jun 08, 2026
pulisher
Jun 08, 2026

Cosmos Health Inc. Subsidiary Cana Laboratories Acquires International Patent to Enhance Nanotechnology Investment Initiatives - Quiver Quantitative

Jun 08, 2026
pulisher
Jun 08, 2026

Cosmos Health Completes Acquisition of Strategic - GlobeNewswire

Jun 08, 2026
pulisher
Jun 08, 2026

New nanotech patent backs Cosmos Health’s next-gen pharma plans - Stock Titan

Jun 08, 2026
pulisher
Jun 05, 2026

Andreas Bovopoulos holds 4.32M Cosmos Health (COSM) shares — Schedule 13G/A - Stock Titan

Jun 05, 2026
pulisher
Jun 05, 2026

Cosmos Health Inc.: Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories - FinanzNachrichten.de

Jun 05, 2026
pulisher
Jun 05, 2026

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories - The Manila Times

Jun 05, 2026
pulisher
Jun 05, 2026

New Oliv18 capsule packs 11 tsp of olive oil for heart support - Stock Titan

Jun 05, 2026
pulisher
Jun 05, 2026

Key facts: Cosmos Health may monetize ~$15M assets; lists 96 products EU - TradingView

Jun 05, 2026
pulisher
Jun 05, 2026

Cosmos Health Inc. (NASDAQ: COSM) $200M shelf; discloses crypto treasury strategy - Stock Titan

Jun 05, 2026
pulisher
Jun 05, 2026

Cosmos Health expands Sky Premium Life to all 27 EU states - Investing.com UK

Jun 05, 2026
pulisher
Jun 05, 2026

Cosmos Health launches Fort18 men’s wellness supplement in U.S. - Investing.com

Jun 05, 2026
pulisher
Jun 04, 2026

$65.3 Million Revenue in 2025 Followed by Q1 2026 Record of $17.9 Million with Momentum Continuing in Q2 for Diversified Global Heath Leader Cosmos Health Inc. (Nasdaq: COSM) - Barchart.com

Jun 04, 2026
pulisher
Jun 04, 2026

Cosmos Health expands Sky Premium Life to all 27 EU states By Investing.com - Investing.com South Africa

Jun 04, 2026
pulisher
Jun 04, 2026

Vitamins brand Sky Premium Life goes on sale in all 27 EU countries - Stock Titan

Jun 04, 2026
pulisher
Jun 04, 2026

Cosmos Health (COSM) to Explore Monetization of Non-Core Assets - GuruFocus

Jun 04, 2026
pulisher
Jun 04, 2026

Cosmos Health explores sale of non-core assets worth $20M By Investing.com - Investing.com India

Jun 04, 2026
pulisher
Jun 04, 2026

Cosmos Health explores sale of non-core assets worth $20M - Investing.com Nigeria

Jun 04, 2026
pulisher
Jun 04, 2026

Cosmos Health Identifies Approximately $20 Million in - GlobeNewswire

Jun 04, 2026
pulisher
Jun 04, 2026

Cosmos Health Inc. Identifies $20 Million in Non-Core Assets for Potential Monetization - Moomoo

Jun 04, 2026
pulisher
Jun 04, 2026

Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value - The Globe and Mail

Jun 04, 2026
pulisher
Jun 03, 2026

Cosmos Health Bets the Farm—Literally—on a $20 Million Revival Plan - BriefGlance

Jun 03, 2026
pulisher
Jun 03, 2026

Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029 - WBOC TV

Jun 03, 2026
pulisher
Jun 02, 2026

Cosmos Health (NASDAQ: COSM) outlines 2026 proxy, 10M-share equity plan and Series B preferred - Stock Titan

Jun 02, 2026
pulisher
Jun 02, 2026

Cosmos Health reports balance sheet improvements, EIB talks By Investing.com - Investing.com South Africa

Jun 02, 2026
pulisher
Jun 02, 2026

Cosmos Health reports balance sheet improvements, EIB talks - Investing.com

Jun 02, 2026
pulisher
Jun 02, 2026

Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to €25M, Eliminates 38% of Warrant Overhang with No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent S - The Manila Times

Jun 02, 2026
pulisher
Jun 02, 2026

Cosmos Health trims $4.5M debt, weighs €25M EIB deal, drops 38% warrants - Stock Titan

Jun 02, 2026
$0.449
price down icon 0.22%
YI YI
$4.28
price down icon 1.83%
$4.70
price up icon 0.86%
ACH ACH
$3.21
price up icon 17.15%
AHG AHG
$1.37
price down icon 1.44%
Capitalizzazione:     |  Volume (24 ore):